Satsangi, J., Simmons, J., Marshall, S., Mitchell, S., Chapman, R., Welsh, K., & Jewell, D. (2000). CCR5 Delta 32 polymorphism in inflammatory bowel disease: Further association with ulcerative colitis and with primary sclerosing cholangitis.
Chicago Style (17th ed.) CitationSatsangi, J., J. Simmons, S. Marshall, S. Mitchell, R. Chapman, K. Welsh, and D. Jewell. CCR5 Delta 32 Polymorphism in Inflammatory Bowel Disease: Further Association with Ulcerative Colitis and with Primary Sclerosing Cholangitis. 2000.
ציטוט MLASatsangi, J., et al. CCR5 Delta 32 Polymorphism in Inflammatory Bowel Disease: Further Association with Ulcerative Colitis and with Primary Sclerosing Cholangitis. 2000.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.